The balance between pro-inflammatory and anti-inflammatory citokines in septic states;Balance entre citocinas pro y antiinflamatorias en estados sépticos

Medicina Intensiva

Volumn 29, Issue 3, 2005, Pages 151-158

  De Pablo Sanchez R ^a   Monserrat Sanz, J ^b   Prieto Martin A ^b   Reyes Martin E ^b   Alvarez De Mon Soto, M ^a,b   Sanchez Garcia, M ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Anti inflammatory response; Citokines; Pro inflammatory response; Sepsis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; NONHUMAN; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY;

EID: 18744366377     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5691(05)74222-4     Document Type: Review

References (19)

1. Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth. 1996;77:110-7.
2. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, et al. Risk and the efficacy of antiinflammatory agents. Am J Respir Crit Care Med. 2002;166:1197-205.
3. Groeneveld PH, Kwappenberg KM, Langermans JA, Nibbering PH, Curtis L. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis. Cytokine. 1997;9:138-42.
4. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;1:355-7.
5. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771-8.
6. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA. 1995;274:172-7.
7. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A. 1992;89:4845-9.
8. Kasai T, Inada K, Takakuwa T, Yamada Y, Inoue Y, Shimamura T, et al. Anti-inflammatory cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol. 1997; 98:34-42.
9. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103: 565-75.
10. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771-8.
11. Van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 1998;351:950-3.
12. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176-80.
13. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med. 2002; 30:558-63.
14. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun. 1996;64:4733-8.
15. Takala A, Jousela I, Jansson SE, Olkkola KT, Takkunen O, Orpana A, et al. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci (Lond). 1999;97:529-38.
16. Letterio JJ, Roberts AB. TGF-beta: a critical modulator of immune cell function. Clin Immunol Immunopathol. 1997;84: 244-50.
17. Torre D, Tambini R, Aristodemo S, Gavazzeni G, Goglio A, Cantamessa C, et al. Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome. Mediators Inflamm. 2000;9:193-5.
18. Knapp S, Thalhammer F, Locker GJ, Laczika K, Hellenstein U, Frass M, et al. Prognostic value of MIP-1 alpha, TGF-beta 2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsis. Clin Immunol Immunopathol. 1998;87:139-44.
19. Haveman JW, Muller Kobold AC, Tervaert JW, van den Berg HM, Tulleken JE, Kallenberg CG. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth J Med. 1999;55:132-41.